Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review

Johanna Contreras, Jeremy Nussbaum, Peter Cangialosi, Sahityasri Thapi, Ankitha Radakrishnan, Jillian Hall, Prashasthi Ramesh, Maria Giovanna Trivieri, Alejandro Folch Sandoval

Research output: Contribution to journalReview articlepeer-review


Minoritized racial and ethnic groups suffer disproportionately from the incidence and morbidity of pulmonary hypertension (PH), as well as its associated cardiovascular, pulmonary, and systemic conditions. These disparities are largely explained by social determinants of health, including access to care, systemic biases, socioeconomic status, and environment. Despite this undue burden, minority patients remain underrepresented in PH research. Steps should be taken to mitigate these disparities, including initiatives to increase research participation, combat inequities in access to care, and improve the treatment of the conditions associated with PH.

Original languageEnglish
Article number285
JournalJournal of Clinical Medicine
Issue number1
StatePublished - Jan 2024


  • clinical trial representation
  • health disparities
  • pulmonary hypertension
  • social determinants of health


Dive into the research topics of 'Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review'. Together they form a unique fingerprint.

Cite this